The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.
<h4>Background</h4>The clinical benefit of guaiac fecal occult blood tests (FOBT) is now well established for colorectal cancer screening. Growing evidence has demonstrated that epigenetic modifications and fecal microbiota changes, also known as dysbiosis, are associated with CRC pathog...
Main Authors: | Aurelien Amiot, Hicham Mansour, Isabelle Baumgaertner, Jean-Charles Delchier, Christophe Tournigand, Jean-Pierre Furet, Jean-Pierre Carrau, Florence Canoui-Poitrine, Iradj Sobhani, CRC group of Val De Marne |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25025467/?tool=EBI |
Similar Items
-
The Limits and Avoidance of Biases in Metagenomic Analyses of Human Fecal Microbiota
by: Emma Bergsten, et al.
Published: (2020-12-01) -
Preliminary Report on W.I.F.S.
Published: (2013) -
An Eye on the Wnt Inhibitory Factor Wif1
by: Lucia Poggi, et al.
Published: (2018-12-01) -
More on Fecal Occult Blood Test Misuse
by: Clarence Wong, et al.
Published: (2014-01-01) -
Embedded Immunodetection System for Fecal Occult Blood
by: Kai-Wen Lin, et al.
Published: (2021-04-01)